Pre-eclampsia is a pregnancy-related multisystem disorder characterised by elevation of blood pressure and proteinuria, in which oxidative stress may play an important role. Blood pressure is partly controlled by O − 2 production by NADPH/NADH oxidase and recently it was shown that a C242T substitution in the p22phox gene was associated with coronary artery disease, in which elevated blood pressure and oxidative stress are also important pathophysiologic features. Therefore we studied the prevalence of the C242T polymorphism in the NADPH/NADH oxidase gene in women with preeclampsia and/or haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome as compared with women with a normotensive pregnancy. DNA from control women (n = 78), women with pre-eclampsia (n = 40), HELLP syndrome (n = 9) or women with HELLP compli-
Introduction
Pre-eclampsia is a pregnancy-related multi-system disorder with considerable maternal and foetal mortality and morbidity. 1 It is clinically characterised by an elevated blood pressure and proteinuria. Although the pathogenesis of the disorder is not yet elucidated, it is thought that oxidative stress and damage of the endothelium lining the blood vessel wall are important contributing factors. 2 Regulation of blood pressure is partly controlled by NADPH/NADH oxidase, which releases the superoxide anion O cated by pregnancy-induced hypertension or preeclampsia (n = 46) were tested for the presence of the C242T polymorphism by polymerase chain reaction followed by restriction fragment-length polymorphism. The prevalence of the homozygous CC-genotype was similar in the patient groups compared with controls. The allele frequency of the T-allele was 31% in both control and patient groups. In conclusion the C242T polymorphism in the p22phox subunit of the NADPH/NADH oxidase gene is not associated with pre-eclampsia. Therefore, oxidative stress generated by NADPH/NADH oxidase probably does not play a role in the development of pre-eclampsia. dase, mainly on the cell membrane of neutrophils and endothelial cells, suggests that this enzyme may play a role in the pathophysiology of disorders in which oxidative stress is involved. Recently it was shown that a C242T substitution in the gene of the p22phox subunit of NADPH/NADH oxidase, changing histidine-72 to tyrosine in the heme-binding site, which reduces the superoxide production, 4 might reduce the susceptibility to coronary artery disease (CAD) in Japanese populations. 5, 6 Although controversy exists between the reports in Caucasian populations, 7, 8 the C242T polymorphism was associated with progression of CAD. 9 Since the aetiology of CAD seems to be comparable with that of preeclampsia and the higher risk of pre-eclamptic women to develop vascular-related diseases in later life, 10, 11 we studied the prevalence of the CC-genotype, which is associated with highest superoxide production, in women with pre-eclampsia and/or haemolysis, elevated liver enzymes, low platelets (HELLP) syndrome and compared it with controls.
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Materials and methods
The Institutional Medical Ethical Review Committee approved the study protocol. After informed consent was obtained, whole blood from women hospitalised for severe pre-eclampsia (n = 40), women with the HELLP syndrome only (n = 9) or both HELLP syndrome and pre-eclampsia or pregnancy-induced hypertension (n = 46) were collected. Severe preeclampsia was defined according to the ISSHP criteria, being a pregnancy-induced hypertension (diastolic blood pressure у110 mm Hg on two or more occasions, each more than 4 h apart) with proteinuria (protein/creatinine ratio у0.30 g/10 mmol). The HELLP syndrome was biochemically characterised by the simultaneous occurrence of haemolysis (lactic dehydrogenase level Ͼ600 IU/L), elevated liver enzymes (both aspartate and alanine aminotransferase activity Ͼ70 IU/L) and low platelets (thrombocyte count under 100 × 10 9/L ). Women with at least one completed normotensive pregnancy served as control subjects (n = 78). The characteristics of the women studied are depicted in Table 1 .
DNA was isolated using the Puregene genomic DNA isolation kit (Gentra Systems, Minneapolis, USA), according the instructions of the manufacturer. DNA was analysed for the C242T polymorphism in the p22phox subunit of the NADPH/NADH oxidase gene using polymerase chain reaction/ restriction fragment length polymorphism (PCR/RFLP) as described previously. 5 In short, a 348 bp DNA fragment containing the polymorph C242T site was amplified from genomic DNA using sterile H 2 O as a negative control. The PCR product was digested with RsaI. When an allele bears a T instead of a C at position 242 this results in a RsaI digestion site yielding two fragments of 160 bp and 188 bp. Otherwise, when a C is present, the 348 bp PCR product is not digested. The presence of both heterozygous or homozygous polymorph subjects 
Results
A similar distribution of the three possible C242T polymorph genotypes in the p22phox gene of NADPH/NADH oxidase was found in the different patient and control groups ( Table 2 ). This resulted in non-significant odds ratios (95% CI) of 0.95 (0.44 -2.04), 0.87 (0.42-1.81) and 1.9 (0.44 -8.14) for the women with pre-eclampsia, HELLP with preeclampsia or pregnancy-induced hypertension and HELLP solely, respectively. Also the prevalence of the 242 C-or T-genotypes for the total patient population were found to be similar when compared with the control group. The odds ratio (95% CI) of the total patient population compared with controls was 0.97 (0.53-1.77).
The T-allele frequency was 0.31 for both the control and the total patient population.
Discussion
Previously it was shown by Inoue et al 5 that the C242T polymorphism in the p22phox subunit of NADPH/NADH oxidase gene decreased the susceptibility to CAD in a Japanese population. They postulated that this polymorphism in the heme-binding site might have an effect on activity and regulation 4 Since mechanisms contributing to CAD may also be important in the aetiology of pre-eclampsia 2 we hypothesised that women who develop pre-eclampsia may have a higher prevalence of the CC genotype. Although our subgroups are small and as a consequence the power to detect differences is relatively low, the similar distribution of the CC-genotype in the patient and control populations provide evidence that the CC genotype was not associated with pre-eclampsia in a Dutch study population. Our findings in a Caucasian population are in line with the findings of Guzik et al, 4 Gardemann et al, 7 Li et al, 8 and Cahilly, 9 who found similar prevalences of the CC-genotype (45.4%, 44.3%, 45.6%, and 43.5%, respectively) and T-allele frequency (33%, 32%, 34%, and 34%, respectively) in large Caucasian populations. However, in Japanese control subjects the prevalence of the CC genotype was 73.6% 5 or 86.7% 6 compared with 51.3% in our Caucasian population. Racial differences between the two study populations could explain these different findings for the prevalence of the C242T-polymporhic variants in controls.
In conclusion, since pre-eclampsia is a multifactorial condition, 1 in which oxidative stress seems to plays a central role, the finding of a similar distribution of the C242T polymorph variants between patients and controls suggests that superoxide radical production by NADPH/NADH oxidase does not play a role in development of pre-eclampsia. 
